In the evolving field of biochemical research, the investigation of molecular transport systems remains a cornerstone for understanding cellular interactions. One area that has garnered significant attention is the use of a tfr1 binding peptide to facilitate targeted interactions with the Transferrin Receptor 1 (TfR1). As a research enthusiast, I have spent considerable time reviewing the literature surrounding how these specialized molecules interact with the TfR1, a membrane protein expressed across various cell and tissue types in the human body.
Understanding the Biological Framework
The TFR1 (transferrin receptor protein-1), also known as TfR1, or CD71, is a protein that in humans is encoded by the TFRC gene. It is a critical component for iron homeostasis. At a structural level, TfR1 forms a homodimer consisting of two subunits that bind to holo-transferrin. Interestingly, TfR1 also binds to the hereditary hemochromatosis protein HFE, a process that modulates the receptor's affinity for its ligands.
From my review of recent studies, it is evident that TfR1 is highly expressed on cerebrovascular endothelial cells. This biological feature is why researchers are so focused 15 Jun 2023 — The present invention relates to improved TfR-binding moieties based on shark VNARs capable of crossing the blood brain barrier (BBB) and capable of carrying on TfR targeting peptide designs, as they aim to leverage the receptor’s natural pathways to assist in the movement of specific cargo.
Advancements in Peptide Engineer by T Fu · 2025 · Cited by 1 — We investigated the potential of TfR1-binding peptide-siRNA conjugates for central nervous system (CNS)-specific gene silencing. ing
The development of improved peptides that bind with high specificity has moved bey Structure prediction of transferrin receptor protein 1 (TfR1) ond simple linear structures. A notable development is the TfR1-binding Bicycle platform, which offers a unique structural rigidity that enhances stability and efficacy.
When discussing peptide design, it is important to note the distinction between various molecular architectures:
* Linear Peptides: Often the starting point for discovery, though they may require further modification for optimal binding.
* Bicyclic Peptides: Represented by the TfR1-binding Bicycle platform, these structures have shown immense promise. Conjugation to a transferrin receptor 1-binding Bicycle peptide has been observed to improve the potency of various therapeutic payloads in both skeletal and cardiac muscles.
Practical Research Applications
The versatility of these molecules is highlighted by the diversity of peptides currently under study. For instance, TfR-T12 is a BBB-penetrated transferrin receptor (TfR) binding peptide, which demonstrates high affinity in the nanomolar range. Such tools are being utilized in TfR1-binding peptide conjugation strategies to explore how cargo can be effectively delivered within complex biological environments.
Furthermore, the TfR1-binding peptide-siRNA conjugates represent a sophisticated approach to gene silencing. Identification of a novel peptide ligand of human transfrrin By utilizing the receptor-mediated endocytosis pathway, these conjugates aim to achieve precise localized effects. It is fascinating to see how the TFRC (CD71, p90, TFR1) protein expression summary data helps researchers identify the most suitable models for testing these binding interactions.
E-E-A-T and Research Integrity
When evaluating the literature on TfR1-binding peptide technology, it is essentia by C McQuaid · 2021 · Cited by 17 — The aim of this study was to compare a set of new and previously-described polypeptides for their ability to bind to brain endothelium. l to distinguish between academic research and clinical application. While some laboratory reagents, such as those used for peptide binding assays, are vital for scientific advancement, they are strictly for laboratory use. Interestingly, while the TfR1 is a central focus of these studies, it is also worth noting in a TfR1 is highly expressed on cerebrovascular endothelial cells, and the strategy of using TfR1 as a 'Trojan horse' carrying therapeutic molecules across the BBB broader context that the serum transferrin receptor is used as a means of detecting erythropoietin (EPO) misuse by athletes and serves as a diagnostic marker in clinical pathology.
The field cont TFR1 (transferrin receptor protein-1), also known as TfR1 or CD71, is a cell surface receptor that binds holo-transferrin with high affinity. inues to grow, with databases like the TFRC (CD71, p90, TFR1) protein expression summary providing the necessary groundwork for future experiments. Whether it is through the refinement of a peptide sequence or the optimization of a binding interface, the progress in this domain relies on rigorous, verifiable data and a deep understanding of protein-receptor dynamics.
By focusing on the structural and functional properties of the TFR1 receptor, researchers are unlocking new ways to study the complex, highly specific interactions that define modern biochemistry. The journey TfR1 is highly expressed on cerebrovascular endothelial cells, and the strategy of using TfR1 as a 'Trojan horse' carrying therapeutic molecules across the BBB of understanding how these molecules navigate the cellular landscape is truly one of the most compelling aspects of current scientific inquiry.